Rho GTPases in A549 and Caco-2 cells dominating the endocytic pathways of nanocarbons with different morphologies

Siyang Song1 School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China, [email protected]; [email protected];2 Beijing Key Laboratory of Molecular Pharmaceutics and the State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China, [email protected]; [email protected]

Hongzhe Fu2 Beijing Key Laboratory of Molecular Pharmaceutics and the State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China, [email protected]; [email protected]

Bing He2 Beijing Key Laboratory of Molecular Pharmaceutics and the State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China, [email protected]; [email protected]

Dan Wang3 Pharmaceutics Department, Institute of Medicinal Biotechnology, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100050, China

Mengmeng Qin2 Beijing Key Laboratory of Molecular Pharmaceutics and the State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China, [email protected]; [email protected]

Dan Yang1 School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China, [email protected]; [email protected];2 Beijing Key Laboratory of Molecular Pharmaceutics and the State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China, [email protected]; [email protected]

Dechun Liu2 Beijing Key Laboratory of Molecular Pharmaceutics and the State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China, [email protected]; [email protected]

Ge Song2 Beijing Key Laboratory of Molecular Pharmaceutics and the State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China, [email protected]; [email protected]

Yujie Shi2 Beijing Key Laboratory of Molecular Pharmaceutics and the State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China, [email protected]; [email protected]

Hua Zhang2 Beijing Key Laboratory of Molecular Pharmaceutics and the State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China, [email protected]; [email protected]

Xueqing Wang2 Beijing Key Laboratory of Molecular Pharmaceutics and the State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China, [email protected]; [email protected]

Wenbing Dai2 Beijing Key Laboratory of Molecular Pharmaceutics and the State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China, [email protected]; [email protected]Correspondence[email protected] [email protected]

Qiang Zhang1 School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China, [email protected]; [email protected];2 Beijing Key Laboratory of Molecular Pharmaceutics and the State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China, [email protected]; [email protected]Correspondence[email protected] [email protected]

show all

Rho GTPases in A549 and Caco-2 cells dominating the endocytic pathways of nanocarbons with different morphologies

Articles from other publishers (11)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Rho GTPases in A549 and Caco-2 cells dominating the endocytic pathways of nanocarbons with different morphologies

Citations (12)

Read on this site (1)

Articles from other publishers (11)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date